SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015506
Filing Date
2021-11-10
Accepted
2021-11-10 16:21:31
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20210930x10q.htm   iXBRL 10-Q 2029434
2 EX-31.1 olma-20210930xex31d1.htm EX-31.1 12662
3 EX-31.2 olma-20210930xex31d2.htm EX-31.2 12698
4 EX-32 olma-20210930xex32.htm EX-32 10410
  Complete submission text file 0001558370-21-015506.txt   6724031

Data Files

Seq Description Document Type Size
5 EX-101.SCH olma-20210930.xsd EX-101.SCH 40173
6 EX-101.CAL olma-20210930_cal.xml EX-101.CAL 45873
7 EX-101.DEF olma-20210930_def.xml EX-101.DEF 145812
8 EX-101.LAB olma-20210930_lab.xml EX-101.LAB 425750
9 EX-101.PRE olma-20210930_pre.xml EX-101.PRE 305097
10 EXTRACTED XBRL INSTANCE DOCUMENT olma-20210930x10q_htm.xml XML 1009423
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 211396985
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences